HDAC1/HDAC3 modulates PPARG2 transcription through the sumoylated CEBPD in hepatic lipogenesis

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1783, Issue 10, 2008, Pages 1803-1814

  Lai, Pei Hua ^a,b   Wang, Wen Lin ^b   Ko, Chiung Yuan ^b   Lee, Yi Chao ^b   Yang, Wen Ming ^c   Shen, Tsung Wei ^b   Chang, Wen Chang ^a,b   Wang, Ju Ming ^a,b  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^c NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

Author keywords

CEBPD; HDAC1 3; Lipogenesis; PPARG2; Sumoylation

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN DELTA; HISTONE DEACETYLASE 1; HISTONE DEACETYLASE 3; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; SUMO 1 PROTEIN;

ADIPOCYTE; ARTICLE; COMPLEX FORMATION; GENE ACTIVATION; GENE INACTIVATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; LIPOGENESIS; LIVER METABOLISM; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN INTERACTION; SIGNAL TRANSDUCTION; SUMOYLATION; TRANSCRIPTION REGULATION;

CCAAT-ENHANCER-BINDING PROTEIN-DELTA; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTONE DEACETYLASES; HUMANS; LIPOGENESIS; LIVER; PPAR GAMMA; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; SUMO-1 PROTEIN; TRANSCRIPTION, GENETIC;

EID: 50849106698     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2008.06.008     Document Type: Article

References (58)

1. Jenuwein T., and Allis C.D. Translating the histone code. Science 293 (2001) 1074-1080
2. Yoo E.J., Chung J.J., Choe S.S., Kim K.H., and Kim J.B. Down-regulation of histone deacetylases stimulates adipocyte differentiation. J. Biol. Chem. 281 (2006) 6608-6615
3. Mai A., Massa S., Rotili D., Cerbara I., Valente S., Pezzi R., Simeoni S., and Ragno R. Histone deacetylation in epigenetics: an attractive target for anticancer therapy. Med. Res. Rev. 25 (2005) 261-309
4. Lee J.H., Kim K.A., Kwon K.B., Kim E.K., Lee Y.R., Song M.Y., Koo J.H., Ka S.O., Park J.W., and Park B.H. Diallyl disulfide accelerates adipogenesis in 3T3-L1 cells. Int. J. Mol. Med. 20 (2007) 59-64
5. Rosen E.D. The transcriptional basis of adipocyte development. Prostaglandins Leukot. Essent Fatty Acids 73 (2005) 31-34
6. Fajas L., Fruchart J.C., and Auwerx J. Transcriptional control of adipogenesis. Curr. Opin. Cell Biol. 10 (1998) 165-173
7. Fajas L., Auboeuf D., Raspe E., Schoonjans K., Lefebvre A.M., Saladin R., Najib J., Laville M., Fruchart J.C., Deeb S., Vidal-Puig A., Flier J., Briggs M.R., Staels B., Vidal H., and Auwerx J. The organization, promoter analysis, and expression of the human PPARgamma gene. J. Biol. Chem. 272 (1997) 18779-18789
8. Dubuquoy L., Dharancy S., Nutten S., Pettersson S., Auwerx J., and Desreumaux P. Role of peroxisome proliferator-activated receptor gamma and retinoid × receptor heterodimer in hepatogastroenterological diseases. Lancet 360 (2002) 1410-1418
9. Rahimian R., Masih-Khan E., Lo M., van Breemen C., McManus B.M., and Dube G.P. Hepatic over-expression of peroxisome proliferator activated receptor gamma2 in the ob/ob mouse model of non-insulin dependent diabetes mellitus. Mol. Cell Biochem. 224 (2001) 29-37
10. Vidal-Puig A.J., Considine R.V., Jimenez-Linan M., Werman A., Pories W.J., Caro J.F., and Flier J.S. Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids. J. Clin. Invest. 99 (1997) 2416-2422
11. Pasceri V., Wu H.D., Willerson J.T., and Yeh E.T. Modulation of vascular inflammation in vitro and in vivo by peroxisome proliferator-activated receptor-gamma activators. Circulation 101 (2000) 235-238
12. Arimura N., Horiba T., Imagawa M., Shimizu M., and Sato R. The peroxisome proliferator-activated receptor gamma regulates expression of the perilipin gene in adipocytes. J. Biol. Chem. 279 (2004) 10070-10076
13. Rosen E.D., Hsu C.H., Wang X., Sakai S., Freeman M.W., Gonzalez F.J., and Spiegelman B.M. C/EBPalpha induces adipogenesis through PPARgamma: a unified pathway. Genes Dev. 16 (2002) 22-26
14. Rosen E.D., Sarraf P., Troy A.E., Bradwin G., Moore K., Milstone D.S., Spiegelman B.M., and Mortensen R.M. PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro. Mol. Cell 4 (1999) 611-617
15. Tontonoz P., Hu E., Graves R.A., Budavari A.I., and Spiegelman B.M. mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer. Genes Dev. 8 (1994) 1224-1234
16. Wu Z., Rosen E.D., Brun R., Hauser S., Adelmant G., Troy A.E., McKeon C., Darlington G.J., and Spiegelman B.M. Cross-regulation of C/EBP alpha and PPAR gamma controls the transcriptional pathway of adipogenesis and insulin sensitivity. Mol. Cell 3 (1999) 151-158
17. Yu S., Matsusue K., Kashireddy P., Cao W.Q., Yeldandi V., Yeldandi A.V., Rao M.S., Gonzalez F.J., and Reddy J.K. Adipocyte-specific gene expression and adipogenic steatosis in the mouse liver due to peroxisome proliferator-activated receptor gamma1 (PPARgamma1) overexpression. J. Biol. Chem. 278 (2003) 498-505
18. Schadinger S.E., Bucher N.L., Schreiber B.M., and Farmer S.R. PPARgamma2 regulates lipogenesis and lipid accumulation in steatotic hepatocytes. Am. J. Physiol. Endocrinol. Metab. 288 (2005) E1195-E1205
19. Fox K.E., Fankell D.M., Erickson P.F., Majka S.M., Crossno Jr. J.T., and Klemm D.J. Depletion of cAMP-response element-binding protein/ATF1 inhibits adipogenic conversion of 3T3-L1 cells ectopically expressing CCAAT/enhancer-binding protein (C/EBP) alpha, C/EBP beta, or PPAR gamma 2. J. Biol. Chem. 281 (2006) 40341-40353
20. Salma N., Xiao H., and Imbalzano A.N. Temporal recruitment of CCAAT/enhancer-binding proteins to early and late adipogenic promoters in vivo. J. Mol. Endocrinol. 36 (2006) 139-151
21. Mori T., Sakaue H., Iguchi H., Gomi H., Okada Y., Takashima Y., Nakamura K., Nakamura T., Yamauchi T., Kubota N., Kadowaki T., Matsuki Y., Ogawa W., Hiramatsu R., and Kasuga M. Role of Kruppel-like factor 15 (KLF15) in transcriptional regulation of adipogenesis. J. Biol. Chem. 280 (2005) 12867-12875
22. Yeh W.C., Cao Z., Classon M., and McKnight S.L. Cascade regulation of terminal adipocyte differentiation by three members of the C/EBP family of leucine zipper proteins. Genes Dev. 9 (1995) 168-181
23. Kudo M., Sugawara A., Uruno A., Takeuchi K., and Ito S. Transcription suppression of peroxisome proliferator-activated receptor gamma2 gene expression by tumor necrosis factor alpha via an inhibition of CCAAT/enhancer-binding protein delta during the early stage of adipocyte differentiation. Endocrinology 145 (2004) 4948-4956
24. Pascual G., Fong A.L., Ogawa S., Gamliel A., Li A.C., Perissi V., Rose D.W., Willson T.M., Rosenfeld M.G., and Glass C.K. A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-gamma. Nature 437 (2005) 759-763
25. Wang J.M., Ko C.Y., Chen L.C., Wang W.L., and Chang W.C. Functional role of NF-IL6beta and its sumoylation and acetylation modifications in promoter activation of cyclooxygenase 2 gene. Nucleic Acids Res. 34 (2006) 217-231
26. Ramirez-Zacarias J.L., Castro-Munozledo F., and Kuri-Harcuch W. Quantitation of adipose conversion and triglycerides by staining intracytoplasmic lipids with Oil red O. Histochemistry 97 (1992) 493-497
27. Yang T.T., and Chow C.W. Transcription cooperation by NFAT.C/EBP composite enhancer complex. J. Biol. Chem. 278 (2003) 15874-15885
28. Glaser K.B., Li J., Staver M.J., Wei R.Q., Albert D.H., and Davidsen S.K. Role of class I and class II histone deacetylases in carcinoma cells using siRNA. Biochem. Biophys. Res. Commun. 310 (2003) 529-536
29. Wang J.M., Tseng J.T., and Chang W.C. Induction of human NF-IL6beta by epidermal growth factor is mediated through the p38 signaling pathway and cAMP response element-binding protein activation in A431 cells. Mol. Biol. Cell 16 (2005) 3365-3376
30. MacDougald O.A., and Lane M.D. Transcriptional regulation of gene expression during adipocyte differentiation. Annu. Rev. Biochem. 64 (1995) 345-373
31. Morrison R.F., and Farmer S.R. Hormonal signaling and transcriptional control of adipocyte differentiation. J. Nutr. 130 (2000) 3116S-3121S
32. Oishi Y., Manabe I., Tobe K., Tsushima K., Shindo T., Fujiu K., Nishimura G., Maemura K., Yamauchi T., Kubota N., Suzuki R., Kitamura T., Akira S., Kadowaki T., and Nagai R. Kruppel-like transcription factor KLF5 is a key regulator of adipocyte differentiation. Cell Metab. 1 (2005) 27-39
33. Cao Z., Umek R.M., and McKnight S.L. Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells. Genes Dev. 5 (1991) 1538-1552
34. Kosaki A., and Webster N.J. Effect of dexamethasone on the alternative splicing of the insulin receptor mRNA and insulin action in HepG2 hepatoma cells. J. Biol. Chem. 268 (1993) 21990-21996
35. Gill G. Something about SUMO inhibits transcription. Curr. Opin. Genet. Dev. 15 (2005) 536-541
36. Fu M., Rao M., Bouras T., Wang C., Wu K., Zhang X., Li Z., Yao T.P., and Pestell R.G. Cyclin D1 inhibits peroxisome proliferator-activated receptor gamma-mediated adipogenesis through histone deacetylase recruitment. J. Biol. Chem. 280 (2005) 16934-16941
37. Fajas L., Egler V., Reiter R., Hansen J., Kristiansen K., Debril M.B., Miard S., and Auwerx J. The retinoblastoma-histone deacetylase 3 complex inhibits PPARgamma and adipocyte differentiation. Dev. Cell 3 (2002) 903-910
38. Zhang Y.L., Hernandez-Ono A., Siri P., Weisberg S., Conlon D., Graham M.J., Crooke R.M., Huang L.S., and Ginsberg H.N. Aberrant hepatic expression of PPARgamma2 stimulates hepatic lipogenesis in a mouse model of obesity, insulin resistance, dyslipidemia, and hepatic steatosis. J. Biol. Chem. 281 (2006) 37603-37615
39. Selzner M., and Clavien P.A. Failure of regeneration of the steatotic rat liver: disruption at two different levels in the regeneration pathway. Hepatology 31 (2000) 35-42
40. Yang S.Q., Lin H.Z., Mandal A.K., Huang J., and Diehl A.M. Disrupted signaling and inhibited regeneration in obese mice with fatty livers: implications for nonalcoholic fatty liver disease pathophysiology. Hepatology 34 (2001) 694-706
41. Rudnick D.A. Trimming the fat from liver regeneration. Hepatology 42 (2005) 1001-1003
42. Moon H.S., Lee H.G., Seo J.H., Chung C.S., Kim T.G., Kim I.Y., Lim K.W., Seo S.J., Choi Y.J., and Cho C.S. Down-regulation of PPARgamma2-induced adipogenesis by PEGylated conjugated linoleic acid as the pro-drug: Attenuation of lipid accumulation and reduction of apoptosis. Arch. Biochem. Biophys. 456 (2006) 19-29
43. Kinoshita S., Akira S., and Kishimoto T. A member of the C/EBP family, NF-IL6 beta, forms a heterodimer and transcriptionally synergizes with NF-IL6. Proc. Natl. Acad. Sci. U. S. A. 89 (1992) 1473-1476
44. Tanaka T., Yoshida N., Kishimoto T., and Akira S. Defective adipocyte differentiation in mice lacking the C/EBPbeta and/or C/EBPdelta gene. EMBO J. 16 (1997) 7432-7443
45. Zhang J., Kalkum M., Chait B.T., and Roeder R.G. The N-CoR-HDAC3 nuclear receptor corepressor complex inhibits the JNK pathway through the integral subunit GPS2. Mol. Cell 9 (2002) 611-623
46. Emiliani S., Fischle W., Van Lint C., Al-Abed Y., and Verdin E. Characterization of a human RPD3 ortholog, HDAC3. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 2795-2800
47. Yang W.M., Yao Y.L., Sun J.M., Davie J.R., and Seto E. Isolation and characterization of cDNAs corresponding to an additional member of the human histone deacetylase gene family. J. Biol. Chem. 272 (1997) 28001-28007
48. Dangond F., Foerznler D., Weremowicz S., Morton C.C., Beier D.R., and Gullans S.R. Cloning and expression of a murine histone deacetylase 3 (mHdac3) cDNA and mapping to a region of conserved synteny between murine chromosome 18 and human chromosome 5. Mol. Cell. Biol. Res. Commun. 2 (1999) 91-96
49. Yang W.M., Tsai S.C., Wen Y.D., Fejer G., and Seto E. Functional domains of histone deacetylase-3. J. Biol. Chem. 277 (2002) 9447-9454
50. Li D., Yea S., Li S., Chen Z., Narla G., Banck M., Laborda J., Tan S., Friedman J.M., Friedman S.L., and Walsh M.J. Kruppel-like factor-6 promotes preadipocyte differentiation through histone deacetylase 3-dependent repression of DLK1. J. Biol. Chem. 280 (2005) 26941-26952
51. Chen P.L., Riley D.J., Chen Y., and Lee W.H. Retinoblastoma protein positively regulates terminal adipocyte differentiation through direct interaction with C/EBPs. Genes Dev. 10 (1996) 2794-2804
52. Gery S., Tanosaki S., Hofmann W.K., Koppel A., and Koeffler H.P. C/EBPdelta expression in a BCR-ABL-positive cell line induces growth arrest and myeloid differentiation. Oncogene 24 (2005) 1589-1597
53. Hansen J.B., Petersen R.K., Larsen B.M., Bartkova J., Alsner J., and Kristiansen K. Activation of peroxisome proliferator-activated receptor gamma bypasses the function of the retinoblastoma protein in adipocyte differentiation. J. Biol. Chem. 274 (1999) 2386-2393
54. Huang A.M., Montagna C., Sharan S., Ni Y., Ried T., and Sterneck E. Loss of CCAAT/enhancer binding protein delta promotes chromosomal instability. Oncogene 23 (2004) 1549-1557
55. Kim K.H., Shin H.J., Kim K., Choi H.M., Rhee S.H., Moon H.B., Kim H.H., Yang U.S., Yu D.Y., and Cheong J. Hepatitis B virus × protein induces hepatic steatosis via transcriptional activation of SREBP1 and PPARgamma. Gastroenterology 132 (2007) 1955-1967
56. Lin S.J., Shu P.Y., Chang C., Ng A.K., and Hu C.P. IL-4 suppresses the expression and the replication of hepatitis B virus in the hepatocellular carcinoma cell line Hep3B. J. Immunol. 171 (2003) 4708-4716
57. Yang L., Chan C.C., Kwon O.S., Liu S., McGhee J., Stimpson S.A., Chen L.Z., Harrington W.W., Symonds W.T., and Rockey D.C. Regulation of peroxisome proliferator-activated receptor-gamma in liver fibrosis. Am. J. Physiol. Gastrointest. Liver Physiol. 291 (2006) G902-G911
58. Huang G.C., Zhang J.S., and Tang Q.Q. Involvement of C/EBP-alpha gene in in vitro activation of rat hepatic stellate cells. Biochem. Biophys. Res. Commun. 324 (2004) 1309-1318